Using Argon for Ventilation After Cardiac Arrest
Official title: CardioPulmonary Resuscitation With Argon (CPAr) Trial
Run by Mario Negri Institute for Pharmacological Research · NCT05482945 · Data updated 2026-11-12
This study is testing if using argon gas mixed with oxygen can help protect the brain and heart in people who have just been resuscitated after a cardiac arrest.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Mario Negri Institute for Pharmacological Research Academic / other |
| Locations | 9 sites (Genova, GE and 8 other locations) |
| Status | Recruiting |
| Started | May 30, 2022 |
| Main results expected | March 31, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | September 17, 2025 |
| Trial ID | NCT05482945 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have experienced a witnessed non-traumatic out-of-hospital cardiac arrest with a shockable rhythm.
✕Probably not a fit
Patients who suffered a non-witnessed cardiac arrest or have a non-shockable rhythm will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial investigates the use of argon gas as a ventilation mixture for patients who have been resuscitated from out-of-hospital cardiac arrest. It is a multicenter, randomized, controlled, single-blinded study focusing on safety assessments in a critical patient population. Eligible patients will receive argon in combination with oxygen within four hours of regaining spontaneous circulation, and outcomes will be monitored for six months. The study aims to determine if argon can reduce neurological and myocardial damage following cardiac arrest.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery outcomes for patients resuscitated from cardiac arrest.
How similar studies have gone: Previous studies have shown promising results with argon in animal models, but this is one of the first clinical trials to test its efficacy in humans.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ICU admission after resuscitation from witnessed non-traumatic out-of-hospital cardiac arrest (OHCA) of presumably cardiac etiology with a presenting shockable rhythm; * age ≥ 18 years; * unconsciousness after return of spontaneous circulation (ROSC); * duration of CPR ≤ 40 mins; * initiation of study intervention ≤ 4 hrs from ROSC; * stable SaO2 ≥ 94% with a FiO2 of 30%. Exclusion Criteria: * Non-witnessed CA; * CA of traumatic origin or from a non-presumably cardiac cause; * CA with a non-shockable presenting rhythm (pulseless electrical activity and asystole); * female of childbearing potential defined as younger of 50 years; * pregnancy; * known terminal illness; * pre-CA cerebral performance category (CPC) ≥ 3; * initiation of the study intervention \> 4 hrs from ROSC; * participation to another clinical trial
Where it's running
-
Ospedale Policlinico San Martino di Genova
Genova, Ge, Italy Recruiting -
Ospedale San Gerado
Monza, Mb, Italy Recruiting -
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Milan, Italy Recruiting -
Ospedale Civile Santa Maria degli Angeli di Pordenone
Pordenone, Pordenone, Italy Recruiting -
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, Rm, Italy Recruiting -
Ospedale Santa Chiara di Trento
Trento, Trento, Italy Recruiting
Show 3 more locations
-
Azienda Sanitaria Universitaria Giuliano Isontina (Asugi) di Trieste
Trieste, Ts, Italy Recruiting -
Azienda Ospedaliero - Universitaria di Parma
Parma, Parma, Italy Not yet recruiting -
Arcispedale Santa Maria Nuova di Reggio Emilia
Reggio Emilia, Reggio Emilia, Italy Not yet recruiting
Study contacts
- Principal investigator: Giuseppe Ristagno, MD, PhD — Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Study coordinator: Giulia Merigo, MSc
- Email: giulia.merigo@unimi.it
- Phone: +39 0250320463
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cardiac Arrest: Using Ultrasound to Find Hidden Blood Flow
This study tests whether patients who have out-of-hospital cardiac arrest but no pulse still show some blood flow on ultrasound and whether that finding relates to survival.
-
Low-dose beta-blocker treatment for adults who survived unexplained ventricular fibrillation
This trial will try low-dose beta-blockers in adults who survived an out-of-hospital cardiac arrest with no clear cause to see if it reduces dangerous heart rhythms and ICD therapies.
-
On-scene ECMO for out-of-hospital cardiac arrest in the Moravian-Silesian Region
This project will try starting ECMO (mechanical heart-lung support) on scene for adults who have a witnessed out-of-hospital cardiac arrest to see if earlier support improves outcomes.
-
ICU clinicians' early judgment of six-month recovery after out-of-hospital cardiac arrest
This project will test whether ICU doctors and nurses can, within the first 24 hours after admission, predict a patient's six-month brain recovery and quality of life after an out-of-hospital cardiac arrest.
-
Mobile ECMO team and optimized transport for sudden cardiac arrest in the Moravian-Silesian Region
This project will try using a mobile ECMO team and faster transport to start extracorporeal cardiopulmonary resuscitation (ECPR) sooner for people who have an out-of-hospital cardiac arrest and may benefit from ECPR.
-
Examining complications from mechanical ventilation in cardiac arrest survivors
This study looks at the problems that can happen from using breathing machines in people who survive cardiac arrest to see how these issues affect their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.